but that was a non-randomized and retrospective study [4] . The authors had not mentioned whether percutaneous acetic acid had been given to new HCC that developed after the initial treatment. I believe that they had done so. However, the crux of the problem does not lie on how good is the treatment method but depends on the hepatocarcinogenic potential of the hepatocytes of the liver remnant. Polyprenoic acid, by its action of promoting apotopsis and, maturation of hepatoma cell line was shown to reduce development of second primary HCC after hepatectomy or percutaneous alcohol injection [5] . If proven to be of value, it would be the drug for patients with treated HCC and even for high risk individuals for the development of HCC.
